Evidence map›Paper›PMID 31115671›Full record

ArticleJournal of cancer research and clinical oncology2019

Letter to the editors of the Journal of Cancer Research and Clinical Oncology.

H Matthes, R-D Hofheinz, G Bar-Sela, D Galun, D Martin, R Huber, J Langhorts, P F Matthiessen, F Schad

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of cancer research and clinical oncology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Statement to an Insufficient Systematic Review onEvidence-based complementary and alternative medicine : eCAM · 2020
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

H MatthesInstitute for Social Medicine, Epidemiology and Health Economics and Department of Gastroenterology, Infectiology and Rheumatology, Charité Universitätsmedizin Berlin, Charité CCM and CBF, Berlin, Germany. hmatthes@havelhoehe.de.ORCID http://orcid.org/0000-0002-4053-4379
R-D HofheinzInterdisciplinary Tumour Centre Mannheim, University Medicine of Mannheim, Mannheim, Germany.
G Bar-SelaEmek Medical Center, Afula, Israel.
D GalunClinical Center of Serbia, Belgrade and Medical School, University of Belgrade, Belgrade, Serbia.
D MartinGerhard Kienle Chair for Medical Theory, Integrative and Anthroposophical Medicine, Department of Human Medicine, Faculty of Health, University of Witten/Herdecke, Witten/Herdecke, Germany.
R HuberCenter for Complementary Medicine, Institute for Infection Prevention and Hospital Epidemiology, University of Freiburg, Freiburg, Germany.
J LanghortsClinic for Integrative Medicine and Naturopathy, Social Foundation Bamberg, Klinikum am Bruderwald, Bamberg, Germany.
P F MatthiessenInstitute for Integrative Medicine at the University of Witten/Herdecke, Witten/Herdecke, Germany.
F SchadDepartment of Oncology, Hospital Havelhöhe, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MistletoeMedical Oncology

Identifiers

PMID31115671
PMCPMC11810228

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.